Pediatric Cancer Genetics Research and an Evolving Preventive Ethics Approach for Return of Results after Death of the Subject

McCullough L. B. , “An Ethical Framework for the Responsible Leadership of Accountable Care Organizations,” American Journal of Medical Quality 27, no. 3 (2012): 189–194.

Chervenak F. A. , “Clinical Guides to Preventing Ethical Conflict between Pregnant Women and Their Physicians,” American Journal of Obstetrics and Gynecology 162, no. 2 (1990): 303–307.

Riley B. D. , “Essential Elements of Genetic Cancer Risk Assessment, Counseling, and Testing: Updated Recommendations of the National Society of Genetic Counselors,” Journal of Genetic Counseling 21, no. 2 (2012): 151–161.

U.S. Department of Health & Human Services, “Health Information of Deceased Individuals,” available at <http://www.hhs.gov/ocr/privacy/hipaa/understanding/coveredentities/decedents.html> (last visited August 19, 2015).

American Medical Association, Opinion 5.051 - Confidentiality of Medical Information Postmortem, available at <http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/opinion5051.page?> (last visited August 19, 2015).

Pate v. Threlkel , 661 So.2d 278 (Fla. 1995); Safer v. Pack, 677 A.2d 1188 (NJ 1996).

Texas Constitution and Statutes, TX. Labor Code. Sec. 21.4031 Exceptions to Confidentiality, available at <http://www.statutes.legis.state.tx.us/Docs/LA/htm/LA.21.htm#21.401> (last visited August 19, 2015).

45 C.F.R. § 46.102 (2014).

Allen N. L. , “Biobank Participants' Preferences for Disclosure of Genetic Research Results: Perspectives from the OurGenes, OurHealth, OurCommunity Project,” Mayo Clinic Proceedings 89, no. 6 (2014): 738–746.

Ormondroyd E. , “Disclosure of Genetics Research Results after the Death of the Patient Participant: A Qualitative Study of the Impact on Relatives,” Journal of Genetic Counseling 16, no. 4 (2007): 527–538.

Fernandez C. V. , “Attitudes of Parents toward the Return of Targeted and Incidental Genomic Research Findings in Children,” Genetics in Medicine 16, no. 8 (2014): 633–640.

Wang L. L. , “Clinical Manifestations in a Cohort of 41 Rothmund-Thomson Syndrome Patients,” American Journal of Medical Genetics 102, no. 1 (2001): 11–17.

Cumin I. , “Rothmund-Thomson Syndrome and Osteosarcoma,” Medical and Pediatric Oncology 26, no. 6 (1996): 414–416; Leonard A. , “Osteogenic Sarcoma in the Rothmund-Thomson Syndrome,” Medical and Pediatric Oncology 26, no. 4 (1996): 249–253; Green J. S. , “Rothmund-Thomson Syndrome Complicated by Osteosarcoma,” Pediatric Radiology 28, no. 1 (1998): 48–50.

Kitao S. , “Rothmund-Thomson Syndrome Responsible Gene, RECQL4: Genomic Structure and products,” Genomics 61, no. 3 (1999): 268–276.

Wang L. L. , “Association between Osteosarcoma and Deleterious Mutations in the RECQL4 Gene in Rothmund-Thomson Syndrome,” Journal of the National Cancer Institute 95, no. 9 (2003): 669–674.

Sanchini V. , “Informed Consent as an Ethical Requirement in Clinical Trials: An Old, But Still Unresolved Issue. An Observational Study to Evaluate Patient's Informed Consent Comprehension,” Journal of Medical Ethics 40, no. 4 (2014): 269–275.

Scollon S. , “Obtaining Informed Consent for Clinical Tumor and Germline Exome Sequencing of Newly Diagnosed Childhood Cancer Patients,” Genome Medicine 6, no. 9 (2014): 69.

Yang Y. , “Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders,” New England Journal of Medicine 369, no. 16 (2013): 1502–1511.

Wasserman J. D. , “Prevalence and Functional Consequence of TP53 Mutations in Pediatric Adrenocortical Carcinoma: A Children's Oncology Group Study,” Journal of Clinical Oncology 33, no. 6 (2015): 602–609.

Zawati M. H. , “The Best Interests of the Child and the Return of Results in Genetic Research: International Comparative Perspectives,” BMC Medical Ethics 15 (2014): 72.

Id. citing Ross L. F. , “Technical Report: Ethical and Policy Issues in Genetic Testing and Screening of Children,” Genetics in Medicine 15, no. 3 (2013): 234–245.

Avard D. , “Pediatric Research and the Return of Individual Research Results,” Journal of Law, Medicine & Ethics 39, no. 4 (2011): 593–604, at 601.

Chan B. , “Genomic Inheritances: Disclosing Individual Research Results from Whole-Exome Sequencing to Deceased Participants' Relatives,” American Journal of Bioethics 12, no. 10 (2012): 1–8; Jarvik G. P. , “Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices in Between,” American Journal of Human Genetics 94, no. 6 (2014): 818–826.

Zawati , supra note 20; Clayton E. W. , “Addressing the Ethical Challenges in Genetic Testing and Sequencing of Children,” American Journal of Bioethics 14, no. 3 (2014): 3–9.

McGuire A. L. , “Returning Genetic Research Results: Study Type Matters,” Personalized Medicine 10, no. 1 (2013): 27–34.

Wolf S. M. , “Return of Individual Research Results and Incidental Findings: Facing the Challenges of Translational Science,” Annual Review of Genomics and Human Genetics 14 (2013): 557–577.

Avard , supra note 22.